Table 4. Anastrozole vs Control: multivariant analyses including age, tumour stage, nodal stage, tumour grade, and ER and PR expression.
Overweight+Obese |
Normal weight |
|||
---|---|---|---|---|
HR | 95% CI | HR | 95% CI | |
DFS | ||||
Anastrozole vs Control |
0.94 |
0.62–1.45 |
0.51 |
0.26–1.00 |
Distant recurrence-free survival | ||||
Anastrozole vs Control |
0.97 |
0.47–1.99 |
0.28 |
0.06–1.46 |
Overall survival | ||||
Anastrozole vs Control | 0.90 | 0.51–1.61 | 0.52 | 0.20–1.31 |
Abbreviations: CI=confidence interval; DFS=disease-free survival; HR=hazard ratio.